The table below shows CATALYST PHARMACEUTICALS, INC.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$149.39M
$148.39M
$146.56M
$141.42M
$128.69M
$122.71M
Cost of revenue
$14.47M
$22.65M
$20.61M
$17.91M
$19.28M
$15.40M
Gross profit
-
-
-
-
-
-
R&D
$2.66M
$2.66M
$4.36M
$3.89M
$3.28M
$2.98M
CPRX annual revenue (10-K history)
CATALYST PHARMACEUTICALS, INC. reported annual revenue of $588.99M for fiscal year 2025. That is up 19.8% from $491.73M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
